October 21 Heyue$SKHYNIX
📉 Direction: Long
📍 Initial position: Enter at current price, 965-975
🎯 Zhiying: 990-1020
KOSPI surged 4%, and SK Hynix shares rose over 7%, with strongly bullish macro sentiment.
Capital flows: Short-term (15m/1h) show large net inflows; however, long-term (7D/15D) continue to show massive net outflows$NVDA $SPCX

SOL outlook for this morning
Short
Entry: 106.60 - 106.80 (near the middle band on a rebound; enter only if momentum stalls and a bearish candle forms)
Stop-loss: Above 107.10 (a sustained hold above the middle band invalidates the short setup)
Target: 106.30 (lower band) → 105.80
Long
Entry: 105.90 - 106.10 (near the current lower band; only try if there is a clear sign of a bottom)
Stop-loss: Below 105.50 (a break below the previous low invalidates the long setup)
Target: 106.60 (middle band) → 107.00
Stay flexible in a range-bound market. Wait for a rebound near the middle band to stall bef

Alright come on bruh 😭

Entered KORU at the very bottom at 10.9 last night; it rose above the target price of 11.8$KORU ‌

Urgent warning! $SKHYNIX The market maker is sharpening its knives—are 360 million in shorts about to be wiped out?!
The trend is a raging tiger; going against it means getting liquidated. Capital is lighting the fuse—follow the market maker and reap big gains!
The market picture is crystal clear: the big players are intent on squeezing shorts! Korean stocks are up 7%, sentiment is surging, and whales with 360 million in short positions are all trapped, while the liquidation map shows a graveyard of shorts above 1000! Capital is flowing in aggressively. My take: don’t go against the trend and

$AGT Plunged—what gives this thing the nerve to rise??

BREAKING: STRIVE LISTS SATS PREFERRED STOCK ON NASDAQ
Strive has officially begun trading its Series A perpetual preferred stock, SATS, on Nasdaq after completing an upsized IPO.
Offering size: 7 million shares.
IPO price: $90 per share.
Ticker: SATS.
The IPO raised approximately $630 million at the offering price, before related expenses. This is a notable development in Strive’s capital-raising strategy.

Pinduoduo’s Mac Mini M6 has already dropped to 4,299, and it could fall below 4,000 during Double 11

zcash:native #ZEC #ZCASH #ZECUSD
ZEC PERPETUAL TRADE
SELL SETUP
Short from $1285
Currently $1285
Targeting $1176 or Down
(Trading plan IF ZEC go up to $1348
will add more shorts)
Its not a Financial advice
$BTC $ETH $XRP $ETHUSD

A massive 1.95M ADA (318 positions) are deeply healthy while total at-risk debt is a measly 1.6K ADA out of 321 active loans on @DexHunterIO.
To trigger a liquidation cascade, $SNEK would need to dump over 55% from here.
The supply is locked up, the leverage is secure, and holders are comfy 🐍

Meme fever reignites as major funds aggressively buy 200 million! $SOL A pullback to 105.5 could trigger a short squeeze
Direction: Long (buy the dip on a pullback)
Entry range: 105.5–106.2
Take-profit target: 108.5–110.0
Key points/rationale: Kimchi’s market cap topped 40 million within 1 hour of launch, reigniting interest in the SOL ecosystem. Flow Score +51; 213 million bought aggressively over 7D, with net inflows exceeding 99 million over 1D, as major funds fully returned. Short liquidations are extremely concentrated above, between 108 and 110; a breakout will immediately trigger a sho

10.21 ETH Market Trend Analysis$ETH
The short-term Bollinger chart shows that after the market surged to a high of 2477.70 earlier, it saw a sharp pullback. After testing the lows, it found support and stabilized, gradually forming a choppy upward recovery.#Gate广场新人季
The current price is holding above the Bollinger midline. The upper band acts as resistance, while the midline provides nearby support. The Bollinger Bands are opening slightly, and the short-term recovery’s bullish momentum remains intact. However, selling pressure near the previous high should not be underestimated, and chasin

#CORE Today's interest: 5.7 CORE coins

Yesterday, the INTC long position entered at 90.5 moved above the second target price of 95.5. $INTC ‌

OpenAI bought an AI pharmaceutical company, but not for molecular design
OpenAI acquired Orchestra Bio and folded it into its own life sciences project, Rosalind.
The company does not work on molecular generation. What it does looks very traditional: using AI Agents to help pharmaceutical companies monitor trial schedules and clinical progress, and coordinate production delays.
The official announcement says that a new drug still takes an average of 10 to 15 years.
When large-model companies enter pharmaceuticals, the first thing they capture is not science, but operations.
1. What is the team

Scumbag Watch: SPCX Update 10.21
Big Rocket closed at 147.79 in U.S. trading, down 0.11%. It hit an intraday high of 148.66 and a low of 143.27.
Big Rocket released its Q3 earnings report after hours, significantly beating expectations. I’ll share a separate breakdown of the report later.
Looking at the candlestick chart first, the stock retested the 60-day moving average again at the U.S. market open, then rebounded and hovered around 147. The stock is now trading around 160 in the overnight session. We can see how long the positive earnings news lasts, especially with a large-scale unlock st

Up 4.26%, with both the 1-hour and 4-hour trends looking strong. $UNI is currently at 7.57 USDT, but 1-hour trading participation is only 0.90x. The 24-hour low is 7.097 and the high is 7.705. Price has clearly pushed higher, but volume hasn’t followed—that’s the most awkward part of this chart.
So I’d rather treat this move toward 7.705 as something that still needs validation, rather than a completed breakout. Touching, crossing, and holding above are three different things. The first two can sometimes happen within a single candle; what matters is whether price can stay there afterward.
Her

Bro, you know what’s the saddest part?
We can’t even see who we’re trading against,
yet we’re willingly giving them 15% of the profits.